Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/aid.2007.0219PMID 18327976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda

  2007cited by this paper
• Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

  2007cited by this paper
• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

  2007cited by this paper
• Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

  2006cited by this paper
• The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

  2006cited by this paper
• British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

  2006cited by this paper
• Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

  2006cited by this paper
• Antiretroviral Drug Resistance and Routine Therapy, Cameroon

  2006cited by this paper
• Reasons for Modification of Generic Highly Active Antiretroviral Therapeutic Regimens Among Patients in Southern India

  2006cited by this paper
• Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

  2006cited by this paper
• Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

  2005cited by this paper
• Prevalence, Incidence and Predictors of Severe Anaemia with Zidovudine-Containing Regimens in African Adults with HIV Infection within the Dart Trial

  2005cited by this paper
• Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon

  2005cited by this paper
• British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

  2005cited by this paper
• Lipodystrophy and Dyslipidemia Among Patients Taking First-Line, World Health Organization-Recommended Highly Active Antiretroviral Therapy Regimens in Western India

  2005cited by this paper
• Haematological Changes in Adults Receiving a Zidovudine-Containing Haart Regimen in Combination with Cotrimoxazole in Côte D'ivoire

  2005cited by this paper
• First-line antiretroviral therapy in Africa--how evidence-base are our recommendations?

  2005cited by this paper
• Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults

  2005cited by this paper
• Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

  2004cited by this paper
• Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

  2004cited by this paper
• Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

  2004cited by this paper
• Beyond randomised versus observational studies.

  2004cited by this paper
• The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

  2002cited by this paper
• Medium-Term Survival, Morbidity and Immunovirological Evolution in HIV-Infected Adults Receiving Antiretroviral Therapy, Abidjan, Côte D'Ivoire

  2002cited by this paper
• A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

  2001cited by this paper
• Etiology and natural history of neutropenia in human immunodeficiency virus disease: a prospective study.

  2001cited by this paper
• Randomized, controlled trials, observational studies, and the hierarchy of research designs.

  2000cited by this paper
• Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients

  2000cited by this paper
• A comparison of observational studies and randomized, controlled trials.

  2000cited by this paper
• British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

  2000cited by this paper

• Time to develop adverse drug reactions and associated factors among children HIV positive patients on antiretroviral treatment in North West Amhara Specialized Hospitals: Retrospective cohort study, 2022

  2024cites this paper
• A retrospective study to evaluate the pattern of spontaneously reported antiretroviral induced adverse drug reactions in a tertiary care hospital

  2018cites this paper
• Title Predictors of persistent Anaemia in the first year of antiretroviral therapy : A retrospective cohort study from Goma , the Democratic Republic of Congo

  2018cites this paper
• Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study

  2017cites this paper
• Evaluation of efficacy of regimens containing zidovudine, stavudine and tinofovir

  2016cites this paper
• A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children

  2016cites this paper
• Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study

  2016cites this paper
• Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo

  2015cites this paper
• Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.

  2015cites this paper
• Genetics of HIV-associated sensory neuropathy in black Southern Africans

  2014cites this paper
• Factors associated with developing symptomatic HIV-associated sensory neuropathy

  2014cites this paper
• COMPARATIVE STUDY OF THE EFFECTS OF ANTIRETROVIRAL THERAPY (ART) ON CD 4 CELL COUNT IN JIMMA UNIVERSITY SPECIALIZED HOSPITAL, JIMMA TOWN, OROMIA REGION, ETHIOPIA

  2014cites this paper
• Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?

  2014cites this paper
• Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy

  2013cites this paper
• Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen

  2013influential citation
• Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa

  2013cites this paper
• A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients

  2013cites this paper
• Is it Time to Abandon Stavudine? The Safety and Tolerability of Low Dose Stavudine versus Zidovudine in Urban Kenya

  2013cites this paper
• AZT impairs immunolog ical recovery on first-line ART: collaborative analysis of cohort studies in Southern Africa

  2013cites this paper
• Adverse Reactions Associated with Antiretroviral Regimens in Adult Patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: An Observational Cohort Study

  2012influential citation
• Mortality and Treatment Failure among HIV-Infected Adults in Dar Es Salaam, Tanzania

  2012cites this paper
• Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya

  2012cites this paper
• Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America

  2012cites this paper
• Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria

  2012cites this paper
• Hematological and Metabolic Toxicities of Current Antiretroviral Regimens in Ahmadu Bello University Teaching Hospital Shika Zaria, Northern Nigeria

  2012cites this paper
• HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury

  2012cites this paper
• Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA

  2012cites this paper
• Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome

  2012cites this paper
• Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis

  2011cites this paper
• Long‐term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral‐naive patients: a 9‐year cohort study in Senegal

  2011cites this paper
• Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.

  2011cites this paper
• PREVALENCE OF ADVERSE DRUG REACTIONS IN ADULT PATIENTS ON ANTI-RETROVIRALS AT KENYATTA NATIONAL HOSPITAL, COMPREHENSIVE CARE CENTRE

  2010cites this paper
• Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.

  2010cites this paper
• HIV‐1 reverse transcriptase drug‐resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon

  2010cites this paper
• Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.

  2009cites this paper
• Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon

  2009cites this paper
• Pharmacogenetics of African populations : variation in major drug metabolising enzyme genes and potential impact on personalised medicine.

  2009cites this paper
• Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

  2009cites this paper
• Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

  2009cites this paper
• Management of antiretroviral failure and resistance in developing countries

  2009cites this paper
• PATIENT PREFERENCE AND ADHERENCE

  year unknowncites this paper